Clinical Trial Update: Safety and Pharmacokinetic Study of RRx-001 in Cancer Subjects [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetic data for RRx-001 in cancer patients; the trial (solid tumors and lymphomas) has completed and results were posted on 2024-11-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumors

Drugs mentioned

• RRx-001

Snippet

Sponsor: EpicentRx, Inc. | Conditions: Malignant Solid Tumor, Lymphomas | Phase 1 | Status: COMPLETED | Results posted: 2024-11-01